O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+55.65%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$6.98B
AUM Growth
+$6.98B
(+34%)
Cap. Flow
+$27.1M
Cap. Flow
% of AUM
0.39%
Top 10 Holdings %
Top 10 Hldgs %
37.73%
Holding
152
New
37
Increased
17
Reduced
34
Closed
13
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$109M |
| 2 |
89bio
ETNB
|
$105M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$104M |
| 4 |
Danaher
DHR
|
$98.1M |
| 5 |
Glaukos
GKOS
|
$84.3M |
Top Sells
| 1 |
AVDR
Avedro, Inc Common Stock
AVDR
|
$96.3M |
| 2 |
WMGI
Wright Medical Group Inc
WMGI
|
$79.2M |
| 3 |
Neurocrine Biosciences
NBIX
|
$68.7M |
| 4 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$58.9M |
| 5 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$56.6M |
Sector Composition
| 1 | Healthcare | 98.02% |
| 2 | Financials | 1.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
CEL-SCI Corp
CVM
$81.4M
| – | – |
0
| – | – |
|
152
iShares Biotechnology ETF
IBB
$5.68B
| – | – |
0
| – | – |
|